| |
Newsroom /
Industry
/
Industry
/
Impact of US Healthcare Reforms - the Extension of Care to 32 Million Uninsured Citizens from 2014
Impact of US Healthcare Reforms - the Extension of Care to 32 Million Uninsured Citizens from 2014
The US healthcare System is the Costliest Healthcare System in the World, Yet it Produces Inferior Outcomes Compared to Other Developed Nations
London,
London,
United Kingdom
(prbd.net)
02/06/2011
GBI Research has found that the US spends the largest sum of money on healthcare, yet produces
inferior outcomes. The US spent $2,486.3 billion on healthcare in 2009, higher than any other
nation in the world. The per capita healthcare spending in the US in 2008 was $7,538, which was
also higher than any other developed nation. Still, the US performs poorly on many health
indicators, including life expectancy and mortality, compared to other developed nations. The
reasons for this poor performance are the lack of universal access to healthcare, overspending by
more than a trillion dollars per year and a faulty payment system that motivates the providers to
offer excess healthcare services without any regard for the quality of service. The healthcare
reforms in the US are trying to address these issues using various measures to improve healthcare
access, reduce waste in the healthcare system and improve the quality of healthcare services.
The healthcare reforms constituted in the Patient Protection and Affordable Care Act (PPACA) and
the Health Care and Education Reconciliation Act of 2010 (HCERA), will bring health insurance
coverage to nearly 32 million non-elderly US residents by 2019. The provisions related to the
expansion of health insurance coverage will start taking effect in 2014. Medicaid expansion to all
non-elderly adults earning less than 133% of the federal poverty level (FPL) will account for 16
million new health insurance beneficiaries and the state-based health insurance exchanges will
account for the rest. Improved access to healthcare as a result of this provision will result in
increased demand for healthcare products and services, which will benefit various suppliers in the
healthcare system including hospitals, pharmaceutical manufacturers, medical device
manufacturers and health insurance companies.
For Sample Pages, please click or add the below link to your browser:
http://www.gbiresearch.com/RequestSamplePages.aspx?ID=Impact-of-US-Healthcare-Reforms-the-Extension-of-Care-to-32-Million-Uninsured-Citizens-from-2014-and-Implications-for-the-Pharmaceutical-Industry&Title=Pharmaceuticals_and_Healthcare&ReportType=Industry_Report
GBI Research, the leading business intelligence provider, has released its latest report, “Impact of
US Healthcare Reforms - the Extension of Care to 32 Million Uninsured Citizens from 2014
and Implications for the Pharmaceutical Industry”, which provides key data, information and
analysis of the US healthcare reforms and their impact.
This report offers a comprehensive insight into the provisions and the impact of the US healthcare
reforms. It provides an overview of the US healthcare system and establishes the need for
healthcare reforms in the US. It talks in detail about the major provisions of the US healthcare
reforms and briefly discusses their implications. It also offers a timeline for the implementation for
the major provisions of the US healthcare reforms. Finally it discusses the impact of the US
healthcare reforms on various stakeholders including the US government, the health insurance
industry, the pharmaceutical and biotechnology industry, the hospitals and the employers.
The report is based on proprietary databases, primary and secondary research and in-house
analysis by GBI Research’s team of industry experts to provide a comprehensive view of the
impact of the US healthcare reforms.
For further details, please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=Impact-of-US-Healthcare-Reforms-the-Extension-of-Care-to-32-Million-Uninsured-Citizens-from-2014-and-Implications-for-the-Pharmaceutical-Industry&Title=Pharmaceuticals_and_Healthcare&ReportType=Industry_Report
Visit our report store: http://www.gbiresearch.com
For more details contact:
pressreleases@gbiresearch.com
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782
About
GBI Research is a global market intelligence services company providing information research and analysis products and services.
|